Clinical trial
Konjac-Mannan (Glucomannan) Improves Glycemia and Other Associated Risk Factors for Coronary Heart Disease in Type 2 Diabetes
NCT03741660 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Konjac-Mannan (Glucomannan) Improves Glycemia and Other Associated Risk Factors for Coronary Heart Disease in Type 2 Diabetes
- Lead sponsor
- Unity Health Toronto
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 1991
- Completion date
- June 30, 1998
- Enrollment
- 11 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
coronary heart disease, type2 diabetes